CHAIR
(S):
SPEAKER
(S):
Errol De Souza, PhD, President & CEO , Archemix Corporation
John Maraganore, PhD, CEO, Alnylam Pharmaceuticals, Inc
John Mendlein, PhD, Chief Executive Officer, Adnexus Therapeutics
Michael Taylor, CEO, Ensemble Discovery Corporation
Steve Wilton, PhD, Professor
Description
"The session will deal with novel emerging therapeutic modalities to address medical needs that cannot be met by existing therapeutic approaches. The opportunities to
complement some established modalities and the challenges
in building business around new therapeutic strategies will be discussed."
Objective 1: Understand the challenges in achieving the HHS Healthy People 2010 goals for immunization coverage.
Objective 2: Determine how to raise awareness of new immunization recommendations for adolescents.
Objective 3: Increase immunization rates among adolescents.